Pfizer's $25 support holds strong, with institutional buying signals and growth potential in oncology. Click here to read an ...

Cryoport stock sees extreme volatility amid growth potential in cell & gene therapy. Read this article to know why I maintain my Sell rating on CYRX.

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

Johnson & Johnson (NYSE:JNJ) experienced an 11% price increase over the last quarter. This movement coincided with several ...

Healthcare diagnostics equipment manufacturer, Idexx Laboratories (NASDAQ: IDXX), is the global leader in pet care. Despite ...

As the incidence of cancer ... of flow cytometry workflows. Rapid advances in automation are improving every step of the flow cytometry process, from sample preparation to data analysis.

Viant Technology's estimated fair value is US$21.01 based on 2 Stage Free Cash Flow to Equity. Viant Technology is estimated to be 37% undervalued based on current s ...

Infusion centers often face unpredictable volumes, which can lead to strained staff and increased wait times for patients during peak hours or underutilized staff and loss of revenue during downtimes.

Despite their established effectiveness, uptake of the WHO best buys for tackling non-communicable diseases (NCDs) has been ...

Your professional path has been a work in progress since spring 2023, and Saturday can clarify the next steps you need to take. An Aries solar (new moon) eclipse—the final one in a three-part ...

particularly given the latest cancer waiting times data. “The impact of cancer is immense. We estimate that half a million people – friends, colleagues and loved ones – will be diagnosed ...

The Oncology Institute, Inc. (NASDAQ: TOI) ("TOI" or the "Company"), one of the largest value-based community oncology groups in the United States ...